N
ETON icon

Nuveen’s Eton Pharmaceutcials ETON Stock Holding History

Nuveen’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Sell
57,950
-967
-2% -$16.9K ﹤0.01% 2403
2025
Q4 		$996K Hold
58,917
– – ﹤0.01% 2618
2025
Q3 		$1.28M Hold
58,917
– – ﹤0.01% 2501
2025
Q2 		$840K Buy
+58,917
New +$931K ﹤0.01% 2685
2021
Q2 		– Sell
-37,204
Closed -$272K – 3421
2021
Q1 		$272K Sell
37,204
-1,951
-5% -$16.6K ﹤0.01% 3192
2020
Q4 		$318K Buy
39,155
+986
+3% +$7.61K ﹤0.01% 3122
2020
Q3 		$301K Hold
38,169
– – ﹤0.01% 3087
2020
Q2 		$208K Buy
+38,169
New +$190K ﹤0.01% 3097

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Nuveen's ETON Position: Q1 2026 in Review

Nuveen reduced its Eton Pharmaceutcials (ETON) stake by 1.6% in Q1 2026, selling an estimated $16.9K and leaving 57,950 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

Nuveen first reported a position in ETON in Q2 2020 and has held it in 8 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Nuveen held 57,950 shares of Eton Pharmaceutcials worth $1.43M as of Q1 2026.
  • Nuveen sold 967 Eton Pharmaceutcials shares in Q1 2026, an estimated $16.9K.
  • Eton Pharmaceutcials made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2403 holding.
  • Nuveen first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 8 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.